BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 51 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $844,752 | +13.7% | 860,000 | +14.7% | 0.00% | – |
| Q2 2022 | $743,000 | -45.0% | 750,000 | -44.4% | 0.00% | -100.0% |
| Q1 2022 | $1,350,000 | +7.7% | 1,350,000 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $1,254,000 | +2.1% | 1,200,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,228,000 | -65.1% | 1,200,000 | -65.5% | 0.00% | -50.0% |
| Q1 2021 | $3,523,000 | -46.6% | 3,481,000 | -43.4% | 0.00% | -50.0% |
| Q4 2020 | $6,595,000 | -14.9% | 6,146,000 | -16.8% | 0.00% | -20.0% |
| Q3 2020 | $7,753,000 | +118.8% | 7,389,000 | +154.8% | 0.01% | +66.7% |
| Q2 2020 | $3,544,000 | -33.8% | 2,900,000 | -43.2% | 0.00% | -40.0% |
| Q1 2020 | $5,352,000 | +0.2% | 5,107,000 | +1.0% | 0.01% | +66.7% |
| Q4 2019 | $5,343,000 | +48.0% | 5,058,000 | +37.7% | 0.00% | 0.0% |
| Q3 2019 | $3,609,000 | -4.1% | 3,672,000 | +1.3% | 0.00% | +50.0% |
| Q2 2019 | $3,762,000 | -31.8% | 3,624,000 | -32.8% | 0.00% | -33.3% |
| Q1 2019 | $5,519,000 | +43.5% | 5,395,000 | +39.5% | 0.00% | 0.0% |
| Q4 2018 | $3,845,000 | -77.9% | 3,868,000 | -76.3% | 0.00% | -40.0% |
| Q3 2018 | $17,414,000 | -8.0% | 16,340,000 | -12.8% | 0.01% | 0.0% |
| Q2 2018 | $18,931,000 | +217.6% | 18,740,000 | +195.1% | 0.01% | +66.7% |
| Q1 2018 | $5,960,000 | -24.8% | 6,351,000 | -20.2% | 0.00% | -40.0% |
| Q4 2017 | $7,925,000 | +143.1% | 7,956,000 | +147.2% | 0.01% | +150.0% |
| Q3 2017 | $3,260,000 | – | 3,218,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SHENKMAN CAPITAL MANAGEMENT INC | 30,138,000 | $29,510,000 | 3.72% |
| PFM Health Sciences, LP | 45,910,000 | $46,002,000 | 1.72% |
| Cheyne Capital Management (UK) LLP | 2,320,000 | $2,330,000 | 1.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 41,077,000 | $41,277,000 | 0.66% |
| SSI INVESTMENT MANAGEMENT LLC | 9,071,000 | $9,068,000 | 0.50% |
| PALISADE CAPITAL MANAGEMENT, LP | 14,548,000 | $14,612,000 | 0.34% |
| RWC Asset Management LLP | 7,500,000 | $7,552,000 | 0.21% |
| KBC Group NV | 400,000 | $40,316,000 | 0.15% |
| PROSPECTOR PARTNERS LLC | 1,000,000 | $1,000,000 | 0.12% |
| MACKAY SHIELDS LLC | 11,822,000 | $11,816,000 | 0.10% |